<DOC>
	<DOCNO>NCT00830388</DOCNO>
	<brief_summary>Ten adult patient age 19 old clinical diagnosis tinea versicolor , well positive Potassium Hydroxide ( KOH ) use calcofluor . Ketoconazole 2 % foam use determine effectiveness , safety satisfaction use treat tinea versicolor .</brief_summary>
	<brief_title>Ketoconazole Foam 2 % Treatment Versicolor</brief_title>
	<detailed_description>Objectives 1 . To assess efficacy ketoconazole 2 % foam treatment tinea versicolor 2 . To assess safety ketoconazole 2 % foam treatment tinea versicolor base occurrence adverse event . 3 . To assess treatment satisfaction rat patient Study Design : This mono-centered , single arm , open-label pilot study . Ten adult patient age 19 old clinical diagnosis tinea versicolor , well positive KOH use calcofluor , enrol University Alabama Birmingham . There 4 schedule visit ( baseline , week 1 , week 2 , week 4 ) . A target area identify mycological clinical assessment perform site well global assessment subject . Ketoconazole 2 % foam apply affected area 2 week follow-up visit week 4 . Skin scrap use disposable # 15 blade calcofluor/potassium hydroxide ( KOH ) assessment photograph target lesion perform baseline , week 1 , week 2 , week 4 . Photographs take baseline week 4 ( KOH positive ) . Body surface area estimation disease also perform visit . Evaluation scale , hyperpigmentation/erythema , hypopigmentation use 4 point scale ( 0 = none , 1 = mild , 2 = moderate , 3 = severe ) target area perform baseline , week 1 , week 2 , week 4 . A global assessment conduct visit use 4 point scale . Patient questionnaire administer baseline week 2 ass symptom satisfaction study medication .</detailed_description>
	<mesh_term>Tinea Versicolor</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>1 . Male female patient , age 19 year . 2 . Clinical presentation tinea versicolor . 3 . Positive KOH use calcofluor . 4 . The ability provide inform consent ( include photography release ) 1 . Use topical antifungal affect area past 30 day 2 . Use topical steroid affect area past 14 day 3 . If female , positive urine pregnancy test screening ( female patient childbearing potential must practice reliable method birth control , plan pregnancy , breastfeed study ) 4 . Patients dermatologic condition region treatment site investigator 's opinion may interfere study result 5 . Current diagnosis immunocompromising condition 6 . Any medical psychiatric condition may interfere treatment compliance</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>tinea versicolor</keyword>
	<keyword>ketoconazole</keyword>
</DOC>